Journal
PHYSIOLOGICAL REVIEWS
Volume 99, Issue 1, Pages 427-511Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/physrev.00061.2017
Keywords
-
Categories
Funding
- Swedish Foundation for International Cooperation in Research and Higher Education (STINT)
- Swedish Research Council [8651]
- Erling-Persson Foundation
- Stockholm City Council [Alf 20150423, 20170133]
- Karolinska Institutet
- Fondazione Istituto di Ricerca Pediatrica-Citta della Speranza
- NIH [NS20480, AG13925, AG041122]
- Connor Group
- Ted Nash Long Life Foundation
- Noaber Foundation
- AFM-Telethon [19524]
- Foundation Leducq
- AIRC [17388]
- RISE [645648]
- CARIPARO
- Telethon grant [GGP14187c]
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020480] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [R37AG013925] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Sarcopenia is a loss of muscle mass and function in the elderly that reduces mobility, diminishes quality of life, and can lead to fall-related injuries, which require costly hospitalization and extended rehabilitation. This review focuses on the aging-related structural changes and mechanisms at cellular and subcellular levels underlying changes in the individual motor unit: specifically, the perikaryon of the alpha-motoneuron, its neuromuscular junction(s), and the muscle fibers that it innervates. Loss of muscle mass with aging, which is largely due to the progressive loss of motoneurons, is associated with reduced muscle fiber number and size. Muscle function progressively declines because motoneuron loss is not adequately compensated by rein-nervation of muscle fibers by the remaining motoneurons. At the intracellular level, key factors are qualitative changes in posttranslational modifications of muscle proteins and the loss of coordinated control between contractile, mitochondrial, and sarcoplasmic reticulum protein expression. Quantitative and qualitative changes in skeletal muscle during the process of aging also have been implicated in the pathogenesis of acquired and hereditary neuromuscular disorders. In experimental models, specific intervention strategies have shown encouraging results on limiting deterioration of motor unit structure and function under conditions of impaired innervation. Translated to the clinic, if these or similar interventions, by saving muscle and improving mobility, could help alleviate sarcopenia in the elderly, there would be both great humanitarian benefits and large cost savings for health care systems.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available